113 related articles for article (PubMed ID: 2979771)
1. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.
Peters GJ; Van Dijk J; Nadal JC; Van Groeningen CJ; Lankelma J; Pinedo HM
In Vivo; 1987; 1(2):113-7. PubMed ID: 2979771
[TBL] [Abstract][Full Text] [Related]
2. Effects of short term treatment with pentagastrin, proglumide, tamoxifen given separately or together with 5-fluorouracil on the growth in the murine transplantable Colon 38 cancer.
Mełeń-Mucha G
Neoplasma; 2001; 48(2):133-8. PubMed ID: 11478694
[TBL] [Abstract][Full Text] [Related]
3. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
5. Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.
Kawamura K; Tasaki K; Hamada H; Takenaga K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Apr; 7(4):637-43. PubMed ID: 10811483
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
[TBL] [Abstract][Full Text] [Related]
7. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
8. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW; von Borstel R
Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythm-modulated chemotherapy with high dose 5-fluorouracil against gastrointestinal cancers: evaluation and case report.
Kojima H; Sakamoto J; Yasue M
Nagoya J Med Sci; 1999 May; 62(1-2):29-38. PubMed ID: 10504825
[TBL] [Abstract][Full Text] [Related]
12. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.
Hill SR; Pollard LA; Bibby MC
Anticancer Res; 1992; 12(6B):2169-75. PubMed ID: 1295464
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
[TBL] [Abstract][Full Text] [Related]
14. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.
Sugarbaker PH; Gianola FJ; Speyer JC; Wesley R; Barofsky I; Meyers CE
Surgery; 1985 Sep; 98(3):414-22. PubMed ID: 3898450
[TBL] [Abstract][Full Text] [Related]
15. Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells.
Aquino A; Prete SP; Greiner JW; Giuliani A; Graziani G; Turriziani M; De Filippi R; Masci G; Bonmassar E; De Vecchis L
Clin Cancer Res; 1998 Oct; 4(10):2473-81. PubMed ID: 9796980
[TBL] [Abstract][Full Text] [Related]
16. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts.
Houghton JA; Houghton PJ
Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222
[TBL] [Abstract][Full Text] [Related]
17. Modulation of 5-fluorouracil in mice using uridine diphosphoglucose.
Codacci-Pisanelli G; Kralovanszky J; van der Wilt CL; Noordhuis P; Colofiore JR; Martin DS; Franchi F; Peters GJ
Clin Cancer Res; 1997 Feb; 3(2):309-15. PubMed ID: 9815688
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic efficacy of 5-fluorouracil with concurrent thymidine infusion against transplantable colon tumors in rodents.
Danhauser LL; Rustum YM
Cancer Drug Deliv; 1984; 1(4):269-82. PubMed ID: 6549560
[TBL] [Abstract][Full Text] [Related]
20. High-dose 5-fluorouracil with delayed uridine "rescue" in mice.
Martin DS; Stolfi RL; Sawyer RC; Spiegelman S; Young CW
Cancer Res; 1982 Oct; 42(10):3964-70. PubMed ID: 7104997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
